Driehaus Capital Management’s Epizyme, Inc EPZM Stock Holding History

Driehaus Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-35,846	Closed	-$615K	–	673
2017 Q1	$615K	Buy	+35,846	New	+$477K	0.02%	413
2014 Q4	–	Sell	-179,409	Closed	-$4.86M	–	620
2014 Q3	$4.86M	Sell	179,409 -82,952	-32%	-$2.58M	0.19%	145
2014 Q2	$8.16M	Buy	262,361 +63,718	+32%	+$1.5M	0.26%	95
2014 Q1	$4.52M	Sell	198,643 -159,722	-45%	-$4.84M	0.14%	184
2013 Q4	$7.45M	Sell	358,365 -187,510	-34%	-$5.44M	0.27%	112
2013 Q3	$21.9M	Buy	545,875 +341,731	+167%	+$11.6M	0.85%	18
2013 Q2	$5.74M	Buy	+204,144	New	+$5.24M	0.25%	133

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Driehaus Capital Management's EPZM Position: Q2 2017 in Review

Driehaus Capital Management sold out of Epizyme, Inc (EPZM) in Q2 2017, closing a stake of 35,846 shares — an estimated $615K sold.

Driehaus Capital Management first reported a position in EPZM in Q2 2013 and held it in 7 quarters. The position peaked at $21.9M in Q3 2013. 108 funds tracked by Wall St. Rank hold EPZM as of Q2 2017.

Driehaus Capital Management reported no remaining Epizyme, Inc position as of Q2 2017 after selling out during the quarter.
Driehaus Capital Management sold 35,846 Epizyme, Inc shares in Q2 2017, an estimated $615K.
Driehaus Capital Management first reported a position in Epizyme, Inc in Q2 2013 and held it in 7 quarters.
Driehaus Capital Management's Epizyme, Inc position peaked at $21.9M in Q3 2013.
108 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2017.

Based on Driehaus Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.